omniture
GC Corp.

Latest News

GC Genome to Present New Data at AACR 2024

Offering Hope for Enhanced Early Detection and Patient Care in the Battle Against Cancer YONGIN, S...

2024-03-25 21:00 1135

GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024

* Recent updates on its development of LSD treatments were presented YONGIN, South Korea, Feb. 14...

2024-02-14 16:33 1467

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

YONGIN, South Korea, Jan. 22, 2024 /PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that th...

2024-01-23 11:53 1175

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces th...

2023-12-18 09:49 1212

GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia

* To commence operation by 2027…with max. 400K liters of plasma production capacity per annum *...

2023-12-06 08:56 1370

GC Biopharma establishes mRNA production facility in Hwasun, Korea

* Completed the construction of a GMP pilot plant in its Hwasun production plant in Jeollanam-do,...

2023-12-01 16:31 1440

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms Y...

2023-11-20 14:39 1121

GC Genome Enters License Agreement with MP Group

- Collaboration includes the transfer of GC Genome's essential wet lab know-how for SNP genotyping ...

2023-11-10 13:00 1521

The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval

YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has ap...

2023-11-06 09:11 1214

GC Cell Joins U.S Cancer Moonshot Project

Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and ...

2023-10-25 11:27 1365

GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023

- An innovative study of methylation markers and deep learning model enables precise lung cancer di...

2023-10-20 13:10 1120

GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that it has p...

2023-10-11 08:49 1313

GC Biopharma Signs Power Purchase Agreement with SK E&S

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced on today that it ha...

2023-10-10 14:20 1168

FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura

YONGIN, South Korea, Oct. 5, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that GC1126A, ...

2023-10-06 08:12 2176

GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)

* The first clinical trial sample analysis provider to adopt LIMS * To provide enhanced quality ...

2023-09-05 09:57 1187

GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community

With the participation of all affiliated group entities YONGIN, South Korea, Aug. 30, 2023 /PRNewsw...

2023-08-30 16:05 1154

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

YONGIN, South Korea, Aug. 25, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biophar...

2023-08-25 15:14 1396

Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements.

* Analyzed the FDA FAERS data…to compare the thrombotic AEs of Hemlibra vs. FVIII replacements. Y...

2023-08-18 08:58 2014

U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)

YONGIN, South Korea, July 31, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceut...

2023-07-31 13:20 1484

GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients

YONGIN, South Korea, July 26, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnos...

2023-07-27 08:53 1052
123